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Purpose: Although chronic and recurrent rhinosinusitis is prevalent in children, little is known about its 
causes. Here, we investigated the humoral immunity in children with chronic or recurrent rhinosinusitis.
Methods: We examined 16 children attending the outpatient clinic at the CHA Bundang Medical Center 
including 11 boys and 5 girls, aged 3–11 years (mean age, 5.6 years), who had rhinosinusitis for >3 
months or >3 times per year. The complete blood count with differential and total serum concentrations 
of Immunoglobulin (Ig) E, IgA, IgD, IgM, IgG, and IgG subclasses (IgG1, IgG2, IgG3, and IgG4) of all 
children were measured. All subjects received 23-polysaccharide pneumococcal vaccination (PPV), 
and the levels of antibodies to 5 serologic types (4, 6B, 14, 18C, and 23F) of pneumococcal capsular 
polysaccharide antigens were measured before and after vaccination. Post-PPV antibody titers ≥0.35 
μg/mL or with a ≥4-fold increase were considered as positive responses.
Results: The titers of IgG, IgA, IgD, and IgM were within normal range in all 16 children, whereas 
the total IgE concentration was higher than normal in 2 children. IgG1 deficiency was observed in 1 
patient and IgG3 deficiency in 3. After PPV, 1 patient failed to respond to all 5 serologic types, 2 failed to 
respond to 4 serologic types, and 2 failed to respond to 3 serologic types. 
Conclusion: Clinicians should consider the evaluation of humoral immune functions in children with 
chronic or recurrent rhinosinusitis who do not respond to prolonged antibiotic treatment.
Key words: Rhinosinusitis, Humoral immune deficiency, Polysaccharide pneumococcal vaccines
Corresponding author: Man Yong Han, MD
Department of Pediatrics, CHA Bundang Medical 
Center, CHA University, 59 Yatap-ro, Bundang-gu, 
Seongnam 463-712, Korea
Tel: +82-31-780-6262 
Fax: +82-31-780-5239 
E-mail: drmesh@gmail.com
Received: 29 December, 2011
Revised: 14 December, 2012
Accepted: 20 February, 2013
Copyright © 2013 by The Korean Pediatric Society
This is an open-access article distributed under the 
terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/
licenses/by-nc/3.0/) which permits unrestricted non-
commercial use, distribution, and reproduction in any 
medium, provided the original work is properly cited.
Original article
Korean J Pediatr 2013;56(7):286-290
http://dx.doi.org/10.3345/kjp.2013.56.7.286
eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr
Introduction
Rhinosinusitis, defined as an inflammation of the nose and paranasal sinuses, is one 
of the most common disorder in pediatric populations. Although it is difficult to estimate 
the incidence of rhinosinusitis in children, 5–10% of children with upper respiratory 
tract infections will go on to develop acute rhinosinusitis with a subset of children 
progressing on to chronic or recurrent state
1,2). The chronic or recurrent inflammatory 
state disrupt daily activities and impair their quality of life, especially when the symptoms 
are recurrent or chronic. Acute rhinosinusitis is usually infectious whereas the etiology of 
chronic or recurrent rhinosinusitis remains poorly defined. The general consensus is that 
the etiology of chronic or recurrent rhinosinusitis is multifactorial. Factors predisposing to 
the development of chronic or recurrent rhinosinusitis include allergy, various immune-
associated disorders, defects in the mucociliary clearance system, and biofilms-associated 
chronic bacterial infection.
Immunoglobulin (Ig) antibody levels, the four subclasses of human IgG, have an 287 http://dx.doi.org/10.3345/kjp.2013.56.7.286
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important role in host defenses against bacteria and viruses. 
Deficiencies in IgA or IgG are considered to play an important 
role in the development of chronic rhinosinusitis
3). Of the IgG 
subclass deficiencies, IgG2 deficiency has been most closely 
associated with chronic/recurrent rhinosinusitis in children
4,5). 
However, IgG-subclass levels can vary with age and therefore, 
transitory Ig defects may occur as one ages. Additionally, the 
existence of serotype-specific IgG antibodies to pneumococcal 
bacteria may play an important role in the prevention of 
pyogenic infections. Furthermore, antibody response to 
pneumococcal vaccination (PPV) is a good measure of humoral 
immune function
6). A great body of evidence have demonstrated 
a close association between immune function, as measured by 
antibody response to PPV, and recurrent infections, such as 
rhinosinusitis
7,8). To date, however, there have been no studies 
confirming a relationship between humoral immune function 
and antibody titers in a Korean subjects who had vacci nation 
against pneumococcus. Therefore, we sought to ascer  tain the 
association between humoral immune deficiency and chronic 
or recurrent rhinosinusitis in Korean children by measuring 
antibody responses to 23-polysaccharide PPV in children with 
chronic or recurrent rhinosinusitis.
Materials and methods
1. Subjects
The present study involved 16 children attending the outpa-
tient clinic at the CHA Bundang Medical Center, who had 
chronic or recurrent rhinosinusitis for more than 3 months or 
more than three times in a year at the CHA Bundang Medical 
Center between January and July 2007. Informed consent for 
participation was obtained from the guardian of each subject. 
Rhinosinusitis was diagnosed by patient inquiry and subsequent 
examination by an experienced pediatrician according to the 
guidelines of the American Association of Pediatrics
9). Chronic 
rhinosinusitis was defined as episodes of inflammation of the 
paranasal sinuses with the presence of thick nasal discharge 
and productive cough for more than 3 months. Recurrent 
rhinosinusitis was defined as presence of bacterial infection 
of the paranasal sinuses, each lasting less than 30 days and 
separated by intervals of at least 10 days during which the 
patient is asymptomatic
9).
2. Methods
All patients were vaccinated with Streptococcus pneumoniae 
capsular polysaccharide (Pneumo 23, Korean Vaccine Co., 
Seoul, Korea) in the outpatient clinic at the CHA Bundang 
Medical Center. Prior to vaccination, a differential complete 
blood count was performed; erythrocyte sedimentation rate 
(ESR) was measured; and serum concentrations of total IgE, 
IgA, IgD, IgM, and IgG, and the IgG subclasses (i.e., IgG1, IgG2, 
IgG3, and IgG4) were assayed. Igs were analyzed using a BN II 
Nephelometer (Dade Behring, Marburg, Germany). Antibody 
titers to five serologic types of capsular polysaccharide (4, 6B, 
14, 18C, and 23F) were measured in serum samples obtained 
before and 4–6 weeks after vaccination, using third-generation 
enzyme-linked immunosorbent assay, at the Center for Vaccine 
Evaluation and Study at Ewha Womans University. The five 
most common serologic types in Korea
7,10,11) were selected for 
analysis. Antibody titers ≥0.35 μg/mL after vaccination or with 
a ≥4-fold increase were considered positive
12,13). Conversions 
of three of five antibody titers with a <4-fold increase were 
considered abnormal
10,13). Normal ranges for immunoglobulins 
were determined using data of the Mayor Medical Laboratory
14), 
figures from Boston
15), and a Korean database
16).
Results
1. Clinical characteristics of chronic or recurrent rhinosinusitis 
in children 
The present study consisted of 16 patients (11 boys and 5 girls) 
aged between 3 and 11 years, with a mean age of 5.6 years. The 
total blood cell numbers and proportion of white blood cells 
(WBCs) were within normal ranges in all patients, although 
the ESR levels of three children were higher than the reference 
range. All patients had normal CH50 test results (Table 1).
2. Serum immunoglobulin concentrations in patients 
Total IgG, IgA, IgD, and IgM concentrations were normal in 
all patients, when comparing the patients’ results to the test’s 
reference values
14), whereas total IgE concentrations were high in 
two patients. Among the IgG subclasses, all patients had normal 
IgG4 concentration. One patient had an above-normal IgG1 con-
centration and one a below-normal level, and one patient had 
an above-normal IgG2 concentration. One patient had an above-
Table 1. Clinical characteristics of chronic or recurrent rhinosinusitis in 
children (n=16)*
Characteristic Value
Male sex 11
Age (yr) 5.6 ( 3–11)
White blood cell (/μL) 7,788±3,424
Erythrocyte sedimentation rate (mm/hr) 17±11
CH50 test Normal
Values are presented as mean (range) or mean±standard deviation.
*Chronic or recurrent rhinosinusitis patients. http://dx.doi.org/10.3345/kjp.2013.56.7.286
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normal and three a below-normal IgG3 concentration (Table 2).
3. Antibody titers before and after polysaccharide PPV 
Thirteen of the 16 patients (81%) showed normal antibody 
conversion, >0.35 µg/mL, to all five antigens (4, 6B, 14, 18C, 
and 23F) after polysaccharide PPV. Of the three patients who 
showed abnormal conversion, all responded to PS23F and two 
patients responded to PS4. Five patients (31%) did not yield 
a 4-fold increase; of these, two showed a <4-fold increase in 
three polysaccharide-specific antibodies, two showed a <4-fold 
increase in four antibodies, and one showed a <4-fold increase 
in all five antibodies (Table 3).
Table 2. Serum immunoglobulin (Ig) concentrations in patients
Patient no. Age (yr) IgG (mg/dL) IgM (mg/dL) IgA (mg/dL) IgD (mg/dL) IgE (IU/mL) IgG1 (g/L) IgG2 (g/L) IgG3 (g/L) IgG4 (g/L)
1 8 1,200 125.0 163.0 <0.23 50.4 6.15 2.16 0.46 0.21
2 3 1,190 61.7 126.0 <0.23 6.7 6.70 1.15 0.26 0.25
3 6 1,010 197.0 67.0 0.86 25.1 5.11 1.75 0.26 0.20
4 9 838 90.7 127.0 1.95 51.6 6.62 4.39 0.54 0.30
5 5 1,360 107.0 139.0 2.77 151.0 7.12 2.76 0.64 0.09
6 3 1,090 144.0 114.0 2.90 112.0 5.82 1.71 0.50 0.29
7 11 1,430 290.0 278.0 0.83 207.0*
,‡ 6.33 4.05   0.18
†,‡ 0.29
8 3 1,000 127.0 47.0 <0.23 17.3 7.95 1.80 0.39 0.17
9 4 891 50.0 54.3 1.50 55.2 4.51 1.48 0.30 0.16
10 3 985 133.0 49.2 <0.23 31.3 7.42 2.04 0.35 0.25
11 7 1,570 126.0 117.0 <0.23 37.1 10.70*
,‡ 2.16 2.30*
,‡,§ 0.15
12 7 1,100 132.0 166.0 0.32 19.6 6.10 2.41 0.54 0.24
13 7 1,160 195.0 94.9 1.09 241.1*
,‡ 5.61 8.83*
,‡,§  0.14
†,‡,§ 0.48
14 4 750 158.0 112.0 1.15 61.4 2.98
†,‡ 2.25  0.13
† 0.15
15 4 1,060 83.5 50.9 0.43 9.0 7.42 2.28 0.30 0.43
16 6 822 139.0 74.4 1.45 6.10 2.93 0.67 0.28
*Greater than normal. 
†Less than normal, compared with the reference range in Korea; 
‡,§Less than normal, compared with reported reference ranges
14,15).
Table 3. Titers of antibodies to antigens of the polysaccharide pneumococcal vaccine
Patient no.
PS4 PS14 PS6B PS19F PS23F
<4 FI
Post* FI Post FI Post FI Post FI Post FI
1 0.98 3.20 152.13 55.10 3.02 3.50 4.97 1.33 12.88 18.70 3
2 1.43 1.50 0.13
† 1.30 3.39 1.20 11.93 1.10 0.17
† 0.80 5
3 9.12 43.50 10.89 2.30 1.28 2.10 11.93 7.80 6.38 10.80 2
4 8.92 66.80 10.00 13.70 4.37 1.40 22.63 6.30 11.71 58.50 1
5 3.93 40.80 27.37 1.10 1.84 1.60 2.26 0.90 0.62 2.80 4
6 132.90 317.60 0.23
† 1.40 0.77 1.30 1.51 0.70 0.14 1.60 4
7 177.70 906.50 26.02 81.70 33.30 1.50 11.55 0.80 6.88 7.00 2
8 115.70 583.40 4.16 12.40 1.86 1.40 3.15 0.50 0.55 5.30 2
9 188.40 140.50 0.63 1.90 4.50 3.30 6.97 0.90 0.34
† 4.90 3
10 324.30 425.10 4.96 1.20 13.30 20.40 14.69 21.20 0.41 1.80 2
11 71.58 36.20 241.12 258.70 137.05 67.20 131.55 93.30 45.33 59.60 0
12 6.62 6.20 4.11 56.40 54.05 11.20 38.97 2.10 1.18 1.20 2
13 52.83 56.20 43.95 1.10 52.02 11.80 37.57 4.50 19.61 5.10 1
14 32.14 76.50 14.67 2.50 49.78 23.50 34.13 30.20 2.70 0.90 2
15 33.39 13.60 8.72 1.90 26.34 8.30 6.35 2.30 6.05 4.00 2
16 15.65 173.60 4.81 1.40 7.88 6.00 22.42 2.30 7.69 14.20 2
PS, polysaccharide; FI, fold increase. 
*Antibody titer after polysaccharide pneumococcal vaccination. 
†Less than 0.35 μg/mL (protective threshold, >0.35 μg/mL).289 http://dx.doi.org/10.3345/kjp.2013.56.7.286
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Discussion
We found that one patient (6.2%) had an IgG1 deficiency and 
three (18.7%) had an IgG3 deficiency. Based on antibody titers to 
five pneumococcal antigens, we found that 5 of 16 patients (31%) 
showed abnormal humoral immune function. Taken together, 8 
of 16 patients (50%) had abnormal results on immune studies, 
three of whom had IgG subclass deficiency and five of whom 
had abnormal humoral immune function.
The most important measure of humoral immune function 
is assessment of changes in antibody titer after vaccination
6). 
We measured antibodies to five serologic types. We defined a 
significant change as a ≥4-fold increase in at least three titers. 
We found that two patients (12.5%) showed no significant 
increase in three titers (sensitivity, 63.6%; specificity, 87.4%) 
and one showed no significant increase in any of the five 
titers (sensitivity, 72.7%; specificity, 56.8%). A previous study 
consisting of 307 adult patients with chronic rhinosinusitis 
demonstrated that 67 patients of them (21.8%) showed a 
humoral immune deficiency
17,18). Another study by Shapiro et 
al.
19) in 61 children with refractory sinusitis showed that 34 of 
them (55.7%) had abnormal immune results; 11 patients had low 
Ig levels, 6 had low Ig levels and vaccine hyporesponsiveness, 
and 17 had poor vaccine response only. In line with previous 
studies, we found that a high proportion of our patients (5 of the 
16 patients [31%]) demonstrated humoral immune deficiency. 
In contrast, the study by Hidalgo et al.
6) in in 78 children with 
recurrent infections found that only five of them (6.4%) failed 
to develop protective antibody levels after vaccination against 
pneumococcus. Another study examining 245 adult patients 
with chronic rhinosinusitis not responding to prolonged 
antibiotic treatment reported that only 22 patients (9%) showed 
low Ig levels after vaccination against pneumococcus
18). 
Furthermore, it has been suggested that antibody production 
capacity may not have an important role in the development 
of chronic rhino sinusitis. Taken together, humoral immune 
deficiency is not a common cause of chronic rhinosinusitis and 
clinicians should consider other causes of chronic rhinosinusitis 
not responding to proper antibiotic treatment
8).
Although previous studies have demonstrated a relationship 
between IgA and IgG2 deficiencies and chronic rhinosinusitis 
in adults
20,21), we were unable to confirm these data as none of 
our patients showed an IgA or IgG2 deficiency. We found that 
one patient (6.2%) had an IgG1 deficiency and three (18.7%) 
had IgG3 deficiencies. In line with our study, a previous study 
of 30 patients with chronic rhinosinusitis showed that 3, 7, 
14, and 10 patients had IgG1, IgG2, IgG3, and IgG4 deficiencies, 
respectively.
22) Another study of 307 adult patients with chronic 
rhinosinusitis demonstrated that 7 patients (2.2%) had IgA 
deficiencies, 6 (2.0%) IgG2 deficiencies, and 55 (17.9%) IgG3 
deficiencies.
17) Another study consisting of 245 patients with 
chronic rhinosinusitis found that 5 patients (2.0%), 10 patients 
(4.1%), 1 patient (0.4%), and 1 patient (0.4%) had IgG1, IgG2, 
IgG3, and IgG4 deficiencies, respectively, and 5 (2.0%) had 
a common variable immune deficiency
18). A previous study 
comprising 27 allergic respiratory children with recurrent 
sinusitis reported that primary and/or secondary humoral 
immune deficiency is not the main cause of chronic/recurrent 
sinusitis
8). A previous study consisting of 30 Korean children 
demonstrated that there is a close association between immune 
deficiency and recurrent or chronic rhinosinusitis in children
22). 
To the best of our knowledge, there have been no studies 
confirming a relationship between humoral immune function 
and antibody titers in patients with pneumococcemia. While the 
prevalence is not different from our results, the smaller number 
of patients in our study made it difficult to determine the 
prevalence of immunoglobulin deficiencies. Therefore, it is not 
clear whether IgG subclass deficiencies are clinically significant 
in children with chronic or recurrent rhinosinusitis
23). 
The present study has limitations that need to be taken into 
account when considering the study and its contributions. 
Firstly, the present study had no control group. Secondly, it had 
relatively small number of subjects compared with previous 
studies.
In conclusion, we determined immune deficiencies in child-
ren with chronic or recurrent rhinosinusitis by quantitating 
immunoglobulin concentrations and measuring antibody titers 
to PPV and found that a substantial proportion of patients 
with chronic or recurrent rhinosinusitis had abnormal immune 
functions. Therefore, humoral immune deficiency may be 
considered as a cause of chronic or recurrent rhinosinusitis. 
Relevant treatment guidelines and long-term measurement 
of antibody titers may be needed in patients with recurrent or 
chronic rhinosinusitis.
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